{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:40:34Z","timestamp":1793972434977,"version":"4.8.0"},"update-to":[{"DOI":"10.1002\/14651858.cd002207.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,2,6]],"date-time":"2014-02-06T00:00:00Z","timestamp":1391644800000}}],"reference-count":98,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd002207.pub4","type":"journal-article","created":{"date-parts":[[2014,2,6]],"date-time":"2014-02-06T08:21:13Z","timestamp":1391674873000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":687,"title":["Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence"],"prefix":"10.1002","volume":"2014","author":[{"given":"Richard P","family":"Mattick","sequence":"first","affiliation":[{"name":"University of New South Wales; National Drug and Alcohol Research Centre; Sydney New South Wales Australia 2052"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Breen","sequence":"additional","affiliation":[{"name":"University of New South Wales; National Drug and Alcohol Research Centre; Sydney New South Wales Australia 2052"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Kimber","sequence":"additional","affiliation":[{"name":"University of New South Wales; National Drug and Alcohol Research Centre; Sydney New South Wales Australia 2052"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Davoli","sequence":"additional","affiliation":[{"name":"Lazio Regional Health Service; Department of Epidemiology; Via di Santa Costanza, 53 Rome Italy 00199"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,2,6]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD002207.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0376-8716(01)00202-2","article-title":"A controlled trial of buprenorphine treatment for opium dependence: The first experience from Iran","volume":"66","author":"Ahmadi","year":"2002","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1002\/14651858.CD002207.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0740-5472(03)00024-2","article-title":"Methadone versus buprenorphine maintenance for the treatment of heroin-dependent outpatients","volume":"24","author":"Ahmadi","year":"2003","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"9","key":"10.1002\/14651858.CD002207.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1046\/j.1365-2362.2003.01218.x","article-title":"Controlled, randomised trial in maintenance treatment of intravenous buprenorphine dependence with naltrexone, methadone or buprenorphine: A novel study","volume":"33","author":"Ahmadi","year":"2003","journal-title":"European Journal of Clinical Investigation"},{"issue":"1","key":"10.1002\/14651858.CD002207.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0740-5472(03)00141-7","article-title":"Twelve-month maintenance treatment of opium-dependent patients","volume":"26","author":"Ahmadi","year":"2004","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"9","key":"10.1002\/14651858.CD002207.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1046\/j.1360-0443.1999.94913376.x","article-title":"Buprenorphine versus methadone maintenance for the treatment of opioid dependence","volume":"94","author":"Fischer","year":"1999","journal-title":"Addiction"},{"issue":"10","key":"10.1002\/14651858.CD002207.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJMoa022164","article-title":"Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone","volume":"349","author":"Fudala","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"20","key":"10.1002\/14651858.CD002207.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1001\/jama.1992.03480200058024","article-title":"A controlled trial of buprenorphine treatment for opioid dependence","volume":"267","author":"Johnson","year":"1992","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD002207.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0376-8716(95)01186-2","article-title":"A placebo controlled trial of buprenorphine as a treatment for opioid dependence","volume":"40","author":"Johnson","year":"1995","journal-title":"Drug and Alcohol Dependence"},{"issue":"18","key":"10.1002\/14651858.CD002207.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJM200011023431802","article-title":"A comparison of levomethadyl acetate, buprenorphine and methadone for opioid dependence","volume":"343","author":"Johnson","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"9358","key":"10.1002\/14651858.CD002207.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0140-6736(03)12600-1","article-title":"1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: A randomised, placebo-controlled trial","volume":"361","author":"Kakko","year":"2003","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD002207.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1176\/ajp.2007.164.5.797","article-title":"A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomised controlled trial","volume":"164","author":"Kakko","year":"2007","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD002207.pub4-BIB0012|cit12","first-page":"5","article-title":"Buprenorphine-naloxone versus methadone maitenance therapy: A randomised double-blind trial with opioid dependent patients","volume":"10","author":"Kamien","year":"2008","journal-title":"Heroin Addiction and Related Clinical Problems"},{"issue":"6","key":"10.1002\/14651858.CD002207.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00005053-199306000-00004","article-title":"Buprenorphine versus methadone maintenance for opioid dependence","volume":"181","author":"Kosten","year":"1993","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"2","key":"10.1002\/14651858.CD002207.pub4-BIB0014|cit14","first-page":"148","article-title":"Buprenorphine and methadone to opiate addicts--a randomized trial (English abstract only)","volume":"125","author":"Kristensen","year":"2005","journal-title":"Tidsskrift for den Norske Laegeforening"},{"issue":"5","key":"10.1002\/14651858.CD002207.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1360-0443.2002.00090.x","article-title":"A placebo-controlled study of high dose buprenorphine in opiate dependents waiting for medication-assisted rehabilitation in Oslo, Norway","volume":"97","author":"Krook","year":"2002","journal-title":"Addiction"},{"issue":"5","key":"10.1002\/14651858.CD002207.pub4-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/archpsyc.1996.01830050035005","article-title":"A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence","volume":"53","author":"Ling","year":"1996","journal-title":"Archives of General Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD002207.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1360-0443.1998.9344753.x","article-title":"Buprenorphine maintenance treatment of opiate dependence: A multicenter, randomised clinical trial","volume":"93","author":"Ling","year":"1998","journal-title":"Addiction"},{"issue":"14","key":"10.1002\/14651858.CD002207.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1001\/jama.2010.1427","article-title":"Buprenorphine implants for treatment of opioid dependence: A randomized controlled trial","volume":"304","author":"Ling","year":"2010","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD002207.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1080\/10550490490440799","article-title":"Implementing buprenorphine treatment in community settings in Australia: Experiences from the buprenorphine implementation trial","volume":"13 Suppl 1","author":"Lintzeris","year":"2004","journal-title":"American Journal on Addictions"},{"issue":"1-3","key":"10.1002\/14651858.CD002207.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2008.08.006","article-title":"Buprenorphine and methadone maintenance in jail and post-release: A randomized clinical trial","volume":"99","author":"Magura","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1002\/14651858.CD002207.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1360-0443.2003.00335.x","article-title":"Buprenorphine versus methadone maintenance therapy: A randomised double-blind with 405 opioid-dependent patients","volume":"98","author":"Mattick","year":"2003","journal-title":"Addiction"},{"issue":"3","key":"10.1002\/14651858.CD002207.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s00213-005-2239-x","article-title":"Randomised clinical trial to compare the effects of methadone and buprenorphine on the immune system in drug abusers","volume":"179","author":"Neri","year":"2005","journal-title":"Psychopharmacology"},{"issue":"9","key":"10.1002\/14651858.CD002207.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1001\/archpsyc.56.9.812","article-title":"Desipramine in opioid-dependent cocaine abusers maintained on methadone or buprenorphine","volume":"56","author":"Oliveto","year":"1999","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD002207.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0376-8716(00)80006-X","article-title":"Buprenorphine: A controlled trial in the treatment of opioid dependence","volume":"60","author":"Pani","year":"2000","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1002\/14651858.CD002207.pub4-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0376-8716(00)00163-0","article-title":"Double-blind randomised trial of buprenorphine and methadone in opiate dependence","volume":"62","author":"Petitjean","year":"2001","journal-title":"Drug and Alcohol Dependence"},{"issue":"8","key":"10.1002\/14651858.CD002207.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/archpsyc.1997.01830200041006","article-title":"Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse","volume":"54","author":"Schottenfeld","year":"1997","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD002207.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1176\/appi.ajp.162.2.340","article-title":"Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence","volume":"162","author":"Schottenfeld","year":"2005","journal-title":"American Journal of Psychiatry"},{"issue":"9631","key":"10.1002\/14651858.CD002207.pub4-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1016\/S0140-6736(08)60954-X","article-title":"Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial","volume":"371","author":"Schottenfeld","year":"2008","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD002207.pub4-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1017\/S146114570700836X","article-title":"Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome:results form a randomised study","volume":"11","author":"Soyka","year":"2008","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"7","key":"10.1002\/14651858.CD002207.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1176\/ajp.151.7.1025","article-title":"Comparison of buprenorphine and methadone in the treatment of opioid dependence","volume":"151","author":"Strain","year":"1994","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD002207.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF02247469","article-title":"Buprenorphine versus methadone in the treatment of opioid dependent cocaine users","volume":"116","author":"Strain","year":"1994","journal-title":"Psychopharmocology"},{"issue":"1","key":"10.1002\/14651858.CD002207.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/clpt.1988.13","article-title":"A clinical trial of buprenorphine: Comparison with methadone in the detoxification of heroin addicts","volume":"43","author":"Bickel","year":"1988","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD002207.pub4-BIB0033|cit33","first-page":"R52","article-title":"A randomised comparison of methadone against buprenorphine in the treatment of opioid dependency: a feasibility study","volume":"Supplement 2004","author":"Bond","year":"2004","journal-title":"International Journal of Pharmacy Practice"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD002207.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000052035","article-title":"Substitution with buprenorphine in methadone- and morphine sulfate-dependent patients. Preliminary results","volume":"4","author":"Bouchez","year":"1998","journal-title":"European Addiction Research"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD002207.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000052034","article-title":"Comparison of buprenorphine and methadone maintenance in opiate addicts","volume":"4","author":"Eder","year":"1998","journal-title":"European Addiction Research"},{"issue":"2","key":"10.1002\/14651858.CD002207.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1360-0443.2006.01321.x","article-title":"Methadone versus buprenorphine in pregnant addicts: A double-blind, double-dummy comparison study","volume":"101","author":"Fischer","year":"2006","journal-title":"Addiction"},{"issue":"1","key":"10.1002\/14651858.CD002207.pub4-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugalcdep.2003.11.017","article-title":"Buprenorphine versus methadone for opioid dependence: Predictor variables for treatment outcome","volume":"75","author":"Gerra","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1002\/14651858.CD002207.pub4-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1046\/j.1360-0443.2003.00352.x","article-title":"Buprenorphine versus methadone maintenance treatment in an ambulant setting: A health-related quality of life assessment","volume":"98","author":"Giacomuzzi","year":"2003","journal-title":"Addiction"},{"issue":"3","key":"10.1002\/14651858.CD002207.pub4-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jsat.2013.02.008","article-title":"Retention in methadone and buprenorphine treatment among African Americans","volume":"45","author":"Gryczynski","year":"2013","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1002\/14651858.CD002207.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2165\/00019053-200523010-00007","article-title":"A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence","volume":"23","author":"Harris","year":"2005","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1002\/14651858.CD002207.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0376-8716(95)01189-7","article-title":"Buprenorphine treatment of opioid dependence: Clinical trial of daily versus alternate-day dosing","volume":"40","author":"Johnson","year":"1995","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1002\/14651858.CD002207.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.drugalcdep.2004.08.027","article-title":"Randomised controlled study transitioning opioid-dependent pregnant women from short-acting morphine to buprenorphine or methadone","volume":"78","author":"Jones","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1002\/14651858.CD002207.pub4-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2004.11.013","article-title":"Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: Effects on the neonatal abstinence syndrome","volume":"79","author":"Jones","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"issue":"13","key":"10.1002\/14651858.CD002207.pub4-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.3109\/10826084.2010.484474","article-title":"Infant neurobehaviour following prenatal exposure to methadone and buprenorphine: results from the neonatal intensive care unit network neurobehavioural scale","volume":"45","author":"Jones","year":"2010","journal-title":"Substance Use and Misuse"},{"issue":"24","key":"10.1002\/14651858.CD002207.pub4-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone and buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD002207.pub4-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/10550490490435966","article-title":"Depression predicts higher rates of heroin use on desipramine with buprenorphine than with methadone","volume":"13","author":"Kosten","year":"2004","journal-title":"American Journal on Addictions"},{"issue":"2","key":"10.1002\/14651858.CD002207.pub4-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jsat.2006.04.005","article-title":"HIV risk behaviors during pharmacologic treatment for opioid dependence: A comparison of levomethadyl acetate [corrected], buprenorphine, and methadone","volume":"31","author":"Lott","year":"2006","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"11","key":"10.1002\/14651858.CD002207.pub4-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"704","DOI":"10.7326\/0003-4819-152-11-201006010-00003","article-title":"Clinic-based treatment of opioid-dependent HIV-Infected patients versus referral to an opioid treatment program. A randomized trial","volume":"152","author":"Lucas","year":"2010","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD002207.pub4-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.drugalcdep.2004.08.011","article-title":"Buprenorphine treatment for opioid dependence: relative efficacy of daily, twice and thrice weekly dosing","volume":"77","author":"Marsch","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1002\/14651858.CD002207.pub4-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jsat.2012.04.003","article-title":"Medically assisted recovery from opiate dependence within the context of the UK drug strategy: methadone and Suboxone (buprenorphine-naloxone) patients compared","volume":"44","author":"McKeganey","year":"2013","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1-2","key":"10.1002\/14651858.CD002207.pub4-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.drugalcdep.2009.12.008","article-title":"A comparison of methadone, buprenorphine and alpha2 adrenergic agonists for opioid detoxification: A mixed treatment comparison meta analysis","volume":"108","author":"Meader","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1002\/14651858.CD002207.pub4-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.clpt.2003.09.004","article-title":"Randomized trial of buprenorphine for treatment of current opiate and cocaine dependence","volume":"75","author":"Montoya","year":"2004","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD002207.pub4-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/10550887.2012.759872","article-title":"A preliminary study comparing methadone and buprenorphine in patients with chronic pain and coexistent opioid addiction","volume":"32","author":"Neumann","year":"2013","journal-title":"Journal of Addictive Diseases"},{"issue":"2","key":"10.1002\/14651858.CD002207.pub4-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0002-9343(98)00194-6","article-title":"A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic","volume":"105","author":"O'Connor","year":"1998","journal-title":"American Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD002207.pub4-BIB0055|cit55","first-page":"43","article-title":"Cocaine use in buprenorphine vs methadone maintained patients","volume":"3","author":"Oliveto","year":"1994","journal-title":"American Journal on Addictions"},{"issue":"2","key":"10.1002\/14651858.CD002207.pub4-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/14659890701538810","article-title":"A pilot study for a randomized controlled and patient preference trial of buprenorphine versus methadone maintenance treatment in the management of opiate dependent patients","volume":"13","author":"Pinto","year":"2008","journal-title":"Journal of Substance Use"},{"issue":"1","key":"10.1002\/14651858.CD002207.pub4-BIB0057|cit57","first-page":"109","article-title":"Buprenorphine: An alternative to methadone for heroin dependence treatment.","volume":"28","author":"Resnick","year":"1992","journal-title":"Psychopharmacology Bulletin"},{"issue":"4","key":"10.1002\/14651858.CD002207.pub4-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bbi.2007.12.013","article-title":"Buprenorphine and methadone maintenance treatment of heroin addicts preserves immune function","volume":"22","author":"Sacerdote","year":"2008","journal-title":"Brain, Behavior, and Immunity"},{"issue":"1","key":"10.1002\/14651858.CD002207.pub4-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00005053-199801000-00006","article-title":"Prognostic factors in buprenorphine- versus methadone-maintained patients","volume":"186","author":"Schottenfeld","year":"1998","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"11","key":"10.1002\/14651858.CD002207.pub4-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/j.1360-0443.2004.00834.x","article-title":"Evaluation of an injection depot formulation of buprenorphine: placebo comparison","volume":"99","author":"Sigmon","year":"2004","journal-title":"Addiction"},{"issue":"6","key":"10.1002\/14651858.CD002207.pub4-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/JCP.0b013e31818a6d38","article-title":"Cognitive functioning during methadone and buprenorphine treatment: Results of a randomized clinical trial","volume":"28","author":"Soyka","year":"2008","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD002207.pub4-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3109\/00952999409109183","article-title":"Reduction of opiate withdrawal-like symptoms by cocaine abuse during methadone and buprenorphine maintenance","volume":"20","author":"Stine","year":"1994","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"1","key":"10.1002\/14651858.CD002207.pub4-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00004714-199602000-00010","article-title":"Buprenorphine versus methadone in the treatment of opioid dependence: self reports, urinalysis, and addiction severity index","volume":"16","author":"Strain","year":"1996","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD002207.pub4-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000052036","article-title":"Comparison of buprenorphine and methadone in the treatment of opioid dependence","volume":"4 Suppl 1","author":"Uehlinger","year":"1998","journal-title":"Eur Addict Res"},{"issue":"9","key":"10.1002\/14651858.CD002207.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.addbeh.2012.04.011","article-title":"Predictors of attrition with buprenorphine\/naloxone treatment in opioid dependent youth","volume":"37","author":"Warden","year":"2012","journal-title":"Addictive Behaviors"},{"issue":"12","key":"10.1002\/14651858.CD002207.pub4-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/archgenpsychiatry.2011.121","article-title":"Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial","volume":"68","author":"Weiss","year":"2011","journal-title":"Archives of General Psychiatry"},{"issue":"17","key":"10.1002\/14651858.CD002207.pub4-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2008.574","article-title":"Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: A randomized trial","volume":"300","author":"Woody","year":"2008","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD002207.pub4-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0740-5472(02)00222-2","article-title":"Buprenorphine maintenance treatment of heroin dependence: the first experience from Iran","volume":"22","author":"Ahmadi","year":"2002","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1002\/14651858.CD002207.pub4-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.drugalcdep.2011.06.021","article-title":"Results of a pilot randomized controlled trial of buprenorphine for opioid dependent women in the criminal justice system","volume":"119","author":"Cropsey","year":"2011","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1002\/14651858.CD002207.pub4-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1046\/j.1360-0443.2001.9656834.x","article-title":"A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence","volume":"96","author":"Barnett","year":"2001","journal-title":"Addiction"},{"issue":"2","key":"10.1002\/14651858.CD002207.pub4-BIB0071|cit71","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002210","article-title":"LAAM maintenance vs methadone maintenance for heroin dependence","author":"Clark","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1-3","key":"10.1002\/14651858.CD002207.pub4-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.drugalcdep.2007.11.003","article-title":"Mortality prior to, during and after opioid maintenance treatment (OMT): A national prospective cross-registry study","volume":"94","author":"Clausen","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"issue":"9","key":"10.1002\/14651858.CD002207.pub4-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11090","article-title":"Methadone and buprenorphine for the management of opioid dependence; a systematic review and economic evaluation","volume":"11","author":"Connock","year":"2007","journal-title":"Health Technology Assessment"},{"issue":"1-2","key":"10.1002\/14651858.CD002207.pub4-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.drugalcdep.2009.05.021","article-title":"Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved","volume":"105","author":"Degenhardt","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1002\/14651858.CD002207.pub4-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","article-title":"Mortality among regular or dependent users of heroin and other opioids: A systematic review and meta-analysis of cohort studies","volume":"106","author":"Degenhardt","year":"2011","journal-title":"Addiction"},{"issue":"9810","key":"10.1002\/14651858.CD002207.pub4-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0140-6736(11)61138-0","article-title":"Extent of illicit drug use and dependence, and their contribution to the global burden of disease","volume":"379","author":"Degenhardt","year":"2012","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD002207.pub4-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/jama.1965.03090080008002","article-title":"A medical treatment for diacetylmorphine (heroin) addiction: a clinical trial with methadone hydrochloride","volume":"193","author":"Dole","year":"1965","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD002207.pub4-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"346-50","DOI":"10.1097\/00000433-199212000-00017","article-title":"Methadone toxicity causing death in ten subjects starting on a methadone maintenance program.","volume":"13","author":"Drummer","year":"1992","journal-title":"American Journal of Forensic Medicine and Pathology"},{"issue":"3","key":"10.1002\/14651858.CD002207.pub4-BIB0079|cit79","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002208","article-title":"Methadone maintenance at different dosages for opioid dependence","author":"Faggiano","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD002207.pub4-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/clpt.1990.67","article-title":"Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal","volume":"47","author":"Fudala","year":"1990","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD002207.pub4-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1360-0443.2007.02090.x","article-title":"Exposure to opioid maintenance treatment reduces long-term mortality","volume":"103","author":"Gibson","year":"2008","journal-title":"Addiction"},{"issue":"7414","key":"10.1002\/14651858.CD002207.pub4-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD002207.pub4-BIB0083|cit83","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"4","key":"10.1002\/14651858.CD002207.pub4-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/archpsyc.1978.01770280111012","article-title":"Human pharmacology and abuse potential of the analgesic buprenorphine","volume":"35","author":"Jasinski","year":"1978","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD002207.pub4-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/bjc\/azh085","article-title":"The effectiveness of methadone maintenance treatment in controlling crime. An Australian aggregate-level analysis","volume":"45","author":"Lind","year":"2005","journal-title":"Journal of Criminology"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD002207.pub4-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/S0376-8716(03)00059-0","article-title":"Clinical efficacy of buprenorphine: comparisons to methadone and placebo","volume":"70","author":"Ling","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"issue":"9651","key":"10.1002\/14651858.CD002207.pub4-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","article-title":"Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review","volume":"372","author":"Mathers","year":"2008","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD002207.pub4-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/14651858","article-title":"The effectiveness of other opioid replacement therapies: LAAM, heroin, buprenorphine, naltrexone and injectable maintenance","volume-title":"Methadone maintenance and other opioid replacement therapies","author":"Mattick","year":"1998"},{"issue":"3","key":"10.1002\/14651858.CD002207.pub4-BIB0089|cit89","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002209.pub2","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD002207.pub4-BIB0090|cit90","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006318.pub3","article-title":"Maintenance agonist treatments for opiate dependent pregnant women","author":"Minozzi","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD002207.pub4-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/j.1360-0443.2004.00764.x","article-title":"Slow-release oral morphine versus methadone: a crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opioid dependence","volume":"99","author":"Mitchell","year":"2004","journal-title":"Addiction"},{"issue":"9791","key":"10.1002\/14651858.CD002207.pub4-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews","volume":"378","author":"Nelson","year":"2011","journal-title":"Lancet"},{"issue":"7150","key":"10.1002\/14651858.CD002207.pub4-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.317.7150.13","article-title":"Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments","volume":"317","author":"Perneger","year":"1998","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD002207.pub4-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/JCP.0b013e31822cd446","article-title":"Six-year mortality rates of patients in methadone and buprenorphine maintenance therapy: results form a nationally representative cohort study","volume":"31","author":"Soyka","year":"2011","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD002207.pub4-BIB0095|cit95","unstructured":"UNODC World Drug Report 2012 www.unodc.org\/unodc\/en\/data-and-analysis\/WDR-2012.html (accessed 6 January 2014) 2012"},{"issue":"4","key":"10.1002\/14651858.CD002207.pub4-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0899-3289(01)00054-2","article-title":"A meta-analysis comparing the effectiveness of buprenorphine and methadone","volume":"12","author":"West","year":"2000","journal-title":"Journal of Substance Abuse"},{"issue":"1","key":"10.1002\/14651858.CD002207.pub4-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14656566.8.1.1","article-title":"Opioid maintenance: a comparative review of pharmacological strategies","volume":"8","author":"White","year":"2007","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"2","key":"10.1002\/14651858.CD002207.pub4-BIB0098|cit98","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002207.pub3","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD002207.pub4\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T13:17:55Z","timestamp":1698758275000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD002207.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Drugs and Alcohol Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,6]]},"references-count":98,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002207.pub4","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718266798.793517485","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,6]]}}}